Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer

Home
/
update
/
details

Funding Boost: Omega Hospitals Gains Rs 500 Crore from Morgan Stanley PE Asia

NextEdge Admin

20 Jun 2024

1 min 41 sec

Omega Hospitals, known as Hyderabad Institute of Oncology, has secured Rs 500 crore in funding from a fund managed by Morgan Stanley Private Equity Asia. As India’s second largest cancer-focused hospital chain, Omega operates over 10 hospitals with a total capacity exceeding 1,400 beds.

The infusion of capital aims to support Omega Hospitals in expanding its presence across Telangana, Andhra Pradesh, and neighboring states such as Karnataka, Maharashtra, Tamil Nadu, Madhya Pradesh, and West Bengal. The primary objective is to enhance its capability in delivering high-quality, comprehensive cancer care services throughout India. Omega Hospitals enjoys a robust reputation in Andhra Pradesh and Telangana for its excellence in cancer care, distinguished medical professionals, and state-of-the-art facilities.

This partnership with Morgan Stanley PE Asia, marking their second investment in an Indian cancer hospital chain within a year, is expected to expedite Omega Hospitals' journey towards becoming the largest cancer care provider in India in the coming years. Veda Corporate Advisors served as the financial advisors to Omega Hospitals in this transaction.